The Times Of Bengal
For You Forever Yours
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE 2025 ANNUAL FINANCIAL RESULTS & COMPANY UPDATE
NASHVILLE, Tenn., Feb. 24, 2026 /PRNewswire/ — Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it…
Read More
TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results
ANDOVER, Mass., Feb. 24, 2026 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming…
Read More
Health In Tech Appoints Former SAP and IBM Executive Sri Rajagopalan as Chief Technology Officer to Advance AI-driven Enterprise-Grade Platform Growth
STUART, Fla., Feb. 24, 2026 /PRNewswire/ — Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform company, today announced…
Read More
Danaher Announces Quarterly Dividend
WASHINGTON, Feb. 24, 2026 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a…
Read More
Encompass Health recognized for corporate excellence on Fortune and Forbes 2026 lists
BIRMINGHAM, Ala., Feb. 24, 2026 /PRNewswire/ — Encompass Health Corp. (NYSE: EHC), the nation’s largest owner and operator of inpatient…
Read More
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2025 Financial Results and Provides 2026 Financial Guidance
– Record total revenues of $4.3 billion in 2025 (+5% YoY) and $1.2 billion (+10% YoY) in 4Q25 – –…
Read More
HOTH THERAPEUTICS ACCELERATES HT-001 TRIAL ENROLLMENT WITH NEW CLINICAL SITE AS PATIENT DEMAND INCREASES
CLEER-001 Phase 2a Expansion Signals Growing Momentum Behind First-in-Class Therapy for Cancer Patients With No Current FDA-Approved Treatment Option NEW…
Read More
Evolent Announces Fourth Quarter 2025 Results and Full Year 2025 Results
WASHINGTON, Feb. 24, 2026 /PRNewswire/ — Evolent Health, Inc. (NYSE: EVH) (“Evolent” or the “Company”), a company that specializes in…
Read More
Johnson & Johnson seeks FDA approval of IMAAVY® (nipocalimab-aahu) as the first-ever FDA-approved treatment for warm autoimmune hemolytic anemia (wAIHA)
Data from the pivotal ENERGY trial showed IMAAVY® produced a rapid and durable hemoglobin responsea in wAIHA Currently no FDA-approved…
Read More
ALS Network Welcomes ALStogether Slack Community, Expanding Digital Support and National Reach
LOS ANGELES, Feb. 24, 2026 /PRNewswire/ — The ALS Network announces that ALStogether, the rapidly growing online Slack community founded…
Read More